HAEM4:Intestinal T-cell Lymphoma
Primary Author(s)*
Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD
Graphical Data Links
N/A
General Disease Overview / Description of Cancer Category
- Class of mature, peripheral T cell neoplasms of the intestine/ Non-Hodgkin lymphoma
- Enteropathy-associated T-cell lymphoma (EATL) and monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) are well-defined WHO entities.
- Aggressive intestinal T-cell lymphomas that do not fulfil the criteria for EATL or MEITL should be classified as intestinal T-cell lymphoma, not otherwise specified
- Indolent T-cell lymphoproliferative disorder is a provisional entity characterized by clonal small mature monomorphic T-cells primarily involving the GI tract
WHO Classification Pages (Includes Links to Content)[1]
Enteropathy-Associated T-cell Lymphoma
Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
Other Related Pages (Includes Links to Content)
None
Additional Information
None
References
- ↑ Arber DA, et al., (2017). Intestinal T-cell lymphomas, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, and Siebert R, Editors. IARC Press: Lyon, France, p372-380.
Notes
*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.
*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.